GRFS (Grifols SA) Sof foyda

GRFS (Grifols) - kompaniyaning tovar belgisi

GURU.Markets platformasi tomonidan taqdim etilgan Grifols, S.A. (GRFS) moliyaviy foydasi, parametr qiymati 0.53 ga teng bo'lgan foyda dinamikasini namoyish etadi. Grifols, S.A. (GRFS) daromadlari plazmani qayta ishlashdagi global yetakchilik va vertikal integratsiyaga asoslangan. Robotlashtirilgan oqsilni tozalash liniyalari biznes barqarorligini ta'minlaydi, ta'minot ishonchliligi esa farmatsevtika vositalarini havo transporti orqali tashish paytida harorat rejimlariga qat'iy rioya qilinishi bilan kafolatlanadi.

GRFS (Grifols, S.A.) Sof foyda tarixi 04.07.2022dan 30.10.2026gacha

Grifols (GRFS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Grifols Biemat|GRFS - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Grifols Biemat|GRFS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Grifols|GRFS - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi grifols.com|GRFS - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Grifols, S.A.|GRFS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Grifols SA|GRFS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Grifols Biemat|GRFS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Grifols|Shoshilinch likvidlik grifols.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
GRFS - Sof foyda
Kompaniyaning jamlanma tahlili:Grifols, S.A.
Grifols Group asosiy tovari

Bebalga biosafety ko'rsatkichlariga ega bo'lgan plazma asosidagi dori vositalari bo'yicha global yetakchi sifatida Grifols, S.A. (GRFS) xomashyo qayta ishlash hajmlariga bevosita bog'liq bo'lgan pul oqimlarini yaratadi. Ushbu ko'rsatkich barcha xarajatlar chegirilgandan keyingi yakuniy moliyaviy natijani o'lchaydi; shuning uchun kompaniyaning sof operatsion foydasini tahlil qilish qisqa muddatli tebranishlar va biznes marjalarining tizimli qisqarishi o'rtasidagi farqni aniqlash imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|ADPT - Kompaniyaning sof foydasi|celldex.com (CLDX) - Sof daromad|Aurinia Pharmaceuticals Inc. (AUPH) - Kompaniyaning sof foydasi|Sof daromad BioCryst Pharmaceuticals, Inc.|Sof daromad VERA|Sof foyda Dianthus Corp|Kompaniyaning sof foydasi Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Kompaniya foydasi|Sof foyda TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|Pharming - Sof foyda|Yillik sof foyda Nektar Corp (NKTR)|Upstream Bio Inc (UPB) - Kompaniyaning sof foydasi|zenasbio.com - Yakuniy foyda|IMNM (Immunome) - Sof foyda|Gossamer Bio Inc (GOSS) - Sof moliyaviy natija|Sof foyda KALV|SEPN: Soliqdan keyingi foyda|Kompaniyaning sof foydasi Pieris Pharmaceuticals PVLA|savarapharma.com (SVRA) - Kompaniyaning sof daromadi|RIGL - Kompaniyaning sof foydasi|ANAB: Kompaniyaning sof foydasi|Astria Pharma (ATXS) - Kompaniyaning sof foydasi|ENGN - Sof moliyaviy natija|Sof daromad RAPT|JBIO: Yakuniy foyda|Kompaniyaning sof foydasi Aclaris Therapeutics, Inc. (ACRS)|Sof moliyaviy natija Kyverna Therapeutics Inc.|Tiziana Life Sciences PLC - Sof daromad|Sof moliyaviy natija Cabaletta Bio Inc (CABA)|Ventyx Biosciences - Sof foyda|THTX - Sof foyda|AVTX (Avalo Therapeutics) - Sof daromad|ELDN - Sof moliyaviy natija|AGEN (Agenus Inc) - Sof foyda|CLYM - Yillik sof foyda|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|ATYR (atyrpharma.com) - Yakuniy foyda|Sof foyda ADAG (Adagene Inc.)|IMA (ImageneBio) - Soliqdan keyingi foyda|STTK - Kompaniyaning sof foydasi|Sof moliyaviy natija Equillium, Inc. EQ|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda IMUX (Immunic)|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|IFRX: Yakuniy foyda|Sof foyda XFOR|Sof foyda adicetbio.com (ACET)|Kompaniyaning sof foydasi Celularity CELU|Yakuniy foyda INMB|BRNS - Kompaniyaning sof foydasi|Kezar Life Sciences Inc. (KZR) - Sof daromad|SABS: Sof foyda|Akari Therapeutics, Plc (AKTX) - Sof foyda|Sof daromad ENLV|QTTB: Yakuniy foyda|Sof foyda GOVX|Sof moliyaviy natija Edesa Biotech Inc|Kompaniyaning sof foydasi iBio Corp IBIO|CARM - Sof daromad|XTLB - Kompaniyaning sof foydasi|Bolt Biotherapeutics (BOLT) - Sof daromad|HCWB (hcwbiologics.com) - Sof daromad|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Kompaniyaning sof foydasi AIM ImmunoTech|Kompaniya foydasi ADTX (Aditxt Corp)|Sof foyda GRI|XRTX - Kompaniyaning sof daromadi|Sof foyda HIND (Vyome Holdings)|Yillik sof foyda Revelation Biosciences Inc|INDP - Kompaniyaning sof foydasi|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|AFMD - Sof moliyaviy natija|ALLK (Allakos Inc) - Sof foyda|HOOKIPA - Soliqdan keyingi foyda|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|ITOS - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|tcbiopharm.com - Kompaniyaning sof foydasi|THRD - Kompaniyaning sof foydasi